 Ross Kedl
Concepts (485)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| CD8-Positive T-Lymphocytes | 63 | 2025 | 900 | 8.520 |
Why?
| | Immunologic Memory | 29 | 2025 | 353 | 5.200 |
Why?
| | Dendritic Cells | 30 | 2022 | 483 | 3.970 |
Why?
| | T-Lymphocytes | 24 | 2024 | 1996 | 2.330 |
Why?
| | Lymphocyte Activation | 27 | 2022 | 1142 | 2.150 |
Why?
| | Vaccines, Subunit | 6 | 2021 | 49 | 2.070 |
Why?
| | Antigen Presentation | 10 | 2017 | 218 | 1.940 |
Why?
| | CD40 Antigens | 12 | 2021 | 89 | 1.740 |
Why?
| | Antigens | 10 | 2017 | 357 | 1.710 |
Why?
| | Adjuvants, Immunologic | 15 | 2025 | 226 | 1.560 |
Why?
| | Mice, Inbred C57BL | 51 | 2025 | 5757 | 1.550 |
Why?
| | Interleukin-15 | 7 | 2025 | 98 | 1.470 |
Why?
| | Membrane Glycoproteins | 11 | 2014 | 500 | 1.410 |
Why?
| | CD27 Ligand | 4 | 2015 | 9 | 1.410 |
Why?
| | Vaccines | 6 | 2019 | 406 | 1.380 |
Why?
| | T-Lymphocyte Subsets | 8 | 2014 | 417 | 1.320 |
Why?
| | Mice | 77 | 2025 | 17787 | 1.260 |
Why?
| | Interleukins | 5 | 2021 | 250 | 1.260 |
Why?
| | Interferon Type I | 7 | 2017 | 140 | 1.230 |
Why?
| | Animals | 97 | 2025 | 36940 | 1.180 |
Why?
| | Interleukin-27 | 4 | 2024 | 13 | 1.160 |
Why?
| | CD4-Positive T-Lymphocytes | 15 | 2021 | 1091 | 1.140 |
Why?
| | Lymph Nodes | 6 | 2017 | 491 | 1.140 |
Why?
| | Listeria monocytogenes | 6 | 2025 | 126 | 1.080 |
Why?
| | CD8 Antigens | 4 | 2019 | 75 | 1.080 |
Why?
| | Ovalbumin | 14 | 2025 | 183 | 1.010 |
Why?
| | Mice, Transgenic | 21 | 2021 | 2167 | 1.000 |
Why?
| | Immunity, Innate | 7 | 2022 | 828 | 1.000 |
Why?
| | Mice, Knockout | 25 | 2025 | 3015 | 0.990 |
Why?
| | Toll-Like Receptor 7 | 10 | 2014 | 39 | 0.950 |
Why?
| | Tumor Necrosis Factor Receptor Superfamily, Member 7 | 3 | 2015 | 28 | 0.930 |
Why?
| | Interleukin-12 | 8 | 2025 | 121 | 0.930 |
Why?
| | GTP Phosphohydrolases | 1 | 2025 | 93 | 0.900 |
Why?
| | T-Lymphocytes, Helper-Inducer | 3 | 2021 | 137 | 0.890 |
Why?
| | Emergency Responders | 2 | 2021 | 36 | 0.860 |
Why?
| | Melanoma, Experimental | 6 | 2025 | 114 | 0.800 |
Why?
| | Cross-Priming | 4 | 2011 | 15 | 0.790 |
Why?
| | Mitochondrial Proteins | 1 | 2025 | 257 | 0.790 |
Why?
| | Listeriosis | 3 | 2025 | 70 | 0.780 |
Why?
| | Cancer Vaccines | 7 | 2016 | 172 | 0.770 |
Why?
| | B-Lymphocytes | 4 | 2025 | 847 | 0.750 |
Why?
| | Epitopes, T-Lymphocyte | 8 | 2021 | 181 | 0.740 |
Why?
| | Asymptomatic Infections | 1 | 2021 | 30 | 0.700 |
Why?
| | Immunity | 2 | 2019 | 143 | 0.690 |
Why?
| | Signal Transduction | 16 | 2025 | 5079 | 0.660 |
Why?
| | Lymphocyte Depletion | 3 | 2019 | 135 | 0.660 |
Why?
| | Adaptive Immunity | 5 | 2020 | 165 | 0.640 |
Why?
| | Poly I-C | 6 | 2015 | 63 | 0.600 |
Why?
| | Immunity, Cellular | 5 | 2015 | 268 | 0.590 |
Why?
| | Antigens, Viral | 2 | 2014 | 178 | 0.590 |
Why?
| | Interferon-gamma | 4 | 2023 | 789 | 0.580 |
Why?
| | Cell Proliferation | 7 | 2025 | 2475 | 0.570 |
Why?
| | Immunotherapy, Adoptive | 2 | 2025 | 327 | 0.550 |
Why?
| | Cell Differentiation | 12 | 2023 | 1991 | 0.550 |
Why?
| | Toll-Like Receptors | 7 | 2020 | 185 | 0.540 |
Why?
| | Adoptive Transfer | 11 | 2020 | 219 | 0.540 |
Why?
| | Receptors, Antigen, T-Cell | 9 | 2020 | 718 | 0.540 |
Why?
| | Aminoquinolines | 4 | 2005 | 19 | 0.530 |
Why?
| | Vaccination | 9 | 2021 | 1381 | 0.530 |
Why?
| | Bystander Effect | 1 | 2016 | 16 | 0.500 |
Why?
| | Receptors, Cell Surface | 5 | 2005 | 385 | 0.500 |
Why?
| | Receptor, Interferon alpha-beta | 3 | 2017 | 34 | 0.490 |
Why?
| | Interleukin-2 Receptor beta Subunit | 3 | 2025 | 27 | 0.490 |
Why?
| | Cell Movement | 8 | 2022 | 967 | 0.490 |
Why?
| | Endothelium, Lymphatic | 1 | 2015 | 12 | 0.480 |
Why?
| | Cytotoxicity, Immunologic | 7 | 2025 | 224 | 0.470 |
Why?
| | Squalene | 1 | 2015 | 7 | 0.470 |
Why?
| | H-2 Antigens | 5 | 2016 | 115 | 0.460 |
Why?
| | Breeding | 1 | 2014 | 64 | 0.450 |
Why?
| | Carcinoma, Pancreatic Ductal | 3 | 2023 | 289 | 0.440 |
Why?
| | Caspase 1 | 1 | 2015 | 144 | 0.440 |
Why?
| | Housing, Animal | 1 | 2014 | 46 | 0.440 |
Why?
| | Bacterial Vaccines | 1 | 2014 | 63 | 0.440 |
Why?
| | OX40 Ligand | 2 | 2011 | 10 | 0.430 |
Why?
| | Antigens, Neoplasm | 5 | 2018 | 319 | 0.430 |
Why?
| | Caspases | 1 | 2015 | 247 | 0.420 |
Why?
| | Immunization | 9 | 2020 | 411 | 0.420 |
Why?
| | Viral Vaccines | 2 | 2014 | 98 | 0.420 |
Why?
| | Interleukin-18 | 1 | 2015 | 236 | 0.410 |
Why?
| | Cytokines | 13 | 2019 | 2085 | 0.400 |
Why?
| | Cell Lineage | 3 | 2013 | 350 | 0.400 |
Why?
| | Toll-Like Receptor 4 | 1 | 2015 | 273 | 0.390 |
Why?
| | Endothelial Cells | 1 | 2017 | 785 | 0.380 |
Why?
| | Receptors, OX40 | 1 | 2011 | 15 | 0.380 |
Why?
| | Tumor Necrosis Factors | 1 | 2011 | 11 | 0.370 |
Why?
| | Spike Glycoprotein, Coronavirus | 3 | 2022 | 109 | 0.370 |
Why?
| | Up-Regulation | 5 | 2022 | 843 | 0.370 |
Why?
| | T-Cell Antigen Receptor Specificity | 4 | 2016 | 50 | 0.370 |
Why?
| | Spleen | 8 | 2019 | 514 | 0.370 |
Why?
| | Virus Diseases | 1 | 2014 | 212 | 0.370 |
Why?
| | Antibodies, Viral | 6 | 2023 | 625 | 0.370 |
Why?
| | Chemokines | 4 | 2020 | 228 | 0.370 |
Why?
| | Immunity, Humoral | 3 | 2023 | 116 | 0.370 |
Why?
| | Vaccinia | 3 | 2018 | 20 | 0.360 |
Why?
| | Cells, Cultured | 11 | 2019 | 4193 | 0.360 |
Why?
| | Orthomyxoviridae Infections | 3 | 2021 | 67 | 0.350 |
Why?
| | Vaccines, Conjugate | 2 | 2010 | 65 | 0.350 |
Why?
| | Antigen-Presenting Cells | 5 | 2018 | 156 | 0.340 |
Why?
| | Pancreatic Neoplasms | 3 | 2023 | 938 | 0.320 |
Why?
| | Female | 38 | 2025 | 73304 | 0.320 |
Why?
| | Humans | 44 | 2025 | 137585 | 0.310 |
Why?
| | Th1 Cells | 5 | 2019 | 143 | 0.300 |
Why?
| | Industry | 1 | 2009 | 68 | 0.290 |
Why?
| | Career Mobility | 1 | 2009 | 69 | 0.290 |
Why?
| | Lymphocyte Count | 4 | 2021 | 148 | 0.280 |
Why?
| | Basic-Leucine Zipper Transcription Factors | 3 | 2017 | 41 | 0.280 |
Why?
| | Myeloid Cells | 4 | 2021 | 148 | 0.260 |
Why?
| | Career Choice | 1 | 2009 | 219 | 0.260 |
Why?
| | Skin Neoplasms | 2 | 2022 | 855 | 0.260 |
Why?
| | Radiation Chimera | 3 | 2014 | 29 | 0.250 |
Why?
| | Intramolecular Oxidoreductases | 1 | 2006 | 68 | 0.250 |
Why?
| | Universities | 1 | 2009 | 433 | 0.250 |
Why?
| | Toxoplasmosis | 2 | 2024 | 40 | 0.250 |
Why?
| | Toxoplasma | 2 | 2024 | 42 | 0.250 |
Why?
| | Viral Proteins | 2 | 2001 | 342 | 0.250 |
Why?
| | Oligopeptides | 2 | 2012 | 271 | 0.250 |
Why?
| | Binding, Competitive | 2 | 2003 | 202 | 0.240 |
Why?
| | Neoplasm Transplantation | 3 | 2006 | 257 | 0.240 |
Why?
| | CD11b Antigen | 2 | 2014 | 61 | 0.230 |
Why?
| | Mitochondrial Membrane Transport Proteins | 1 | 2025 | 43 | 0.230 |
Why?
| | Mice, 129 Strain | 2 | 2017 | 88 | 0.230 |
Why?
| | Mitochondrial Dynamics | 1 | 2025 | 39 | 0.230 |
Why?
| | CD11c Antigen | 2 | 2008 | 41 | 0.220 |
Why?
| | Mice, Inbred BALB C | 10 | 2020 | 1272 | 0.220 |
Why?
| | Repressor Proteins | 3 | 2017 | 427 | 0.220 |
Why?
| | Seroepidemiologic Studies | 2 | 2021 | 165 | 0.210 |
Why?
| | Monocytes | 4 | 2024 | 563 | 0.210 |
Why?
| | B7-H1 Antigen | 4 | 2021 | 217 | 0.210 |
Why?
| | Influenza A virus | 2 | 2021 | 107 | 0.210 |
Why?
| | Nanoparticles | 2 | 2025 | 481 | 0.210 |
Why?
| | Immunophenotyping | 3 | 2019 | 318 | 0.210 |
Why?
| | Peptide Fragments | 4 | 2016 | 706 | 0.200 |
Why?
| | Omentum | 1 | 2022 | 10 | 0.200 |
Why?
| | Cell Adhesion Molecules | 2 | 2022 | 181 | 0.200 |
Why?
| | Egg Proteins | 2 | 2001 | 17 | 0.200 |
Why?
| | Influenza Vaccines | 3 | 2025 | 539 | 0.200 |
Why?
| | Chemokine CXCL10 | 2 | 2022 | 39 | 0.200 |
Why?
| | Sentinel Lymph Node | 1 | 2022 | 45 | 0.190 |
Why?
| | Transforming Growth Factor beta | 2 | 2019 | 480 | 0.190 |
Why?
| | Imidazoles | 5 | 2014 | 238 | 0.190 |
Why?
| | Graft Rejection | 2 | 2017 | 624 | 0.190 |
Why?
| | Receptors, CXCR3 | 1 | 2022 | 13 | 0.190 |
Why?
| | Gene Expression | 3 | 2016 | 1502 | 0.190 |
Why?
| | Chemokine CXCL9 | 1 | 2022 | 27 | 0.190 |
Why?
| | Gene Rearrangement, T-Lymphocyte | 1 | 2001 | 15 | 0.190 |
Why?
| | Lung | 6 | 2021 | 4060 | 0.190 |
Why?
| | Transcription Factors | 4 | 2023 | 1719 | 0.180 |
Why?
| | Microspheres | 2 | 2021 | 137 | 0.180 |
Why?
| | Immunotherapy | 5 | 2023 | 641 | 0.180 |
Why?
| | Gene Expression Regulation, Neoplastic | 3 | 2022 | 1396 | 0.180 |
Why?
| | Portraits as Topic | 1 | 2021 | 2 | 0.180 |
Why?
| | Microfilament Proteins | 1 | 2022 | 133 | 0.180 |
Why?
| | Disease Models, Animal | 6 | 2025 | 4295 | 0.180 |
Why?
| | Receptors, CCR2 | 1 | 2021 | 40 | 0.180 |
Why?
| | Receptors, Virus | 1 | 2021 | 83 | 0.180 |
Why?
| | Immunologic Factors | 1 | 2003 | 236 | 0.180 |
Why?
| | Mutation | 2 | 2025 | 3958 | 0.180 |
Why?
| | RNA, Messenger | 4 | 2025 | 2833 | 0.180 |
Why?
| | Male | 21 | 2025 | 67762 | 0.180 |
Why?
| | Immunoglobulin M | 2 | 2022 | 289 | 0.180 |
Why?
| | Luminescent Proteins | 1 | 2001 | 179 | 0.170 |
Why?
| | Immunoassay | 1 | 2021 | 115 | 0.170 |
Why?
| | Lipids | 1 | 2025 | 672 | 0.170 |
Why?
| | Immunity, Mucosal | 1 | 2021 | 97 | 0.170 |
Why?
| | Specimen Handling | 1 | 2022 | 183 | 0.170 |
Why?
| | Transcriptional Activation | 2 | 2022 | 378 | 0.170 |
Why?
| | Cell Communication | 4 | 2013 | 315 | 0.160 |
Why?
| | Interleukin-2 | 6 | 2025 | 455 | 0.160 |
Why?
| | Fluorescent Dyes | 1 | 2001 | 321 | 0.160 |
Why?
| | Actins | 1 | 2022 | 416 | 0.160 |
Why?
| | Tumor Necrosis Factor-alpha | 3 | 2005 | 1242 | 0.160 |
Why?
| | Primary Cell Culture | 2 | 2021 | 171 | 0.160 |
Why?
| | Phosphoproteins | 1 | 2022 | 338 | 0.160 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2022 | 220 | 0.160 |
Why?
| | Glycoproteins | 1 | 2001 | 342 | 0.160 |
Why?
| | Integrin alpha Chains | 3 | 2019 | 24 | 0.160 |
Why?
| | Liposomes | 5 | 2025 | 223 | 0.160 |
Why?
| | Macrophages | 2 | 2021 | 1547 | 0.160 |
Why?
| | Disease Resistance | 1 | 2019 | 34 | 0.150 |
Why?
| | Joints | 1 | 2020 | 105 | 0.150 |
Why?
| | Costimulatory and Inhibitory T-Cell Receptors | 1 | 2019 | 7 | 0.150 |
Why?
| | Chikungunya Fever | 1 | 2020 | 79 | 0.150 |
Why?
| | Allergens | 2 | 2021 | 409 | 0.150 |
Why?
| | Homeostasis | 2 | 2016 | 621 | 0.150 |
Why?
| | Chikungunya virus | 1 | 2020 | 80 | 0.150 |
Why?
| | Aerobiosis | 1 | 2018 | 21 | 0.150 |
Why?
| | T-Box Domain Proteins | 1 | 2019 | 98 | 0.150 |
Why?
| | Antineoplastic Agents, Immunological | 1 | 2021 | 190 | 0.150 |
Why?
| | Antibodies, Monoclonal | 4 | 2019 | 1430 | 0.150 |
Why?
| | Flow Cytometry | 5 | 2016 | 1178 | 0.150 |
Why?
| | Immune Tolerance | 3 | 2012 | 363 | 0.150 |
Why?
| | Mitochondria | 1 | 2025 | 948 | 0.150 |
Why?
| | Hypersensitivity | 1 | 2021 | 257 | 0.140 |
Why?
| | Multiple Sclerosis | 1 | 2024 | 455 | 0.140 |
Why?
| | Gene Expression Regulation | 6 | 2013 | 2607 | 0.140 |
Why?
| | Peptides | 5 | 2013 | 985 | 0.140 |
Why?
| | Cell Membrane | 1 | 2001 | 738 | 0.140 |
Why?
| | Vaccines, DNA | 2 | 2009 | 32 | 0.140 |
Why?
| | Vaccinia virus | 3 | 2010 | 43 | 0.140 |
Why?
| | Autoimmunity | 3 | 2025 | 908 | 0.140 |
Why?
| | Lymphocytes | 2 | 2022 | 397 | 0.140 |
Why?
| | Interleukin-10 | 1 | 2019 | 302 | 0.140 |
Why?
| | Antigens, CD | 4 | 2019 | 521 | 0.130 |
Why?
| | Gene Products, gag | 3 | 2006 | 36 | 0.130 |
Why?
| | Killer Cells, Natural | 2 | 2019 | 449 | 0.130 |
Why?
| | Head and Neck Neoplasms | 1 | 2022 | 606 | 0.130 |
Why?
| | Friend murine leukemia virus | 1 | 2017 | 30 | 0.130 |
Why?
| | Transplantation Tolerance | 1 | 2017 | 36 | 0.130 |
Why?
| | Protein Tyrosine Phosphatases | 1 | 2018 | 172 | 0.130 |
Why?
| | Cytidine Deaminase | 1 | 2017 | 61 | 0.130 |
Why?
| | Glycolysis | 1 | 2018 | 321 | 0.130 |
Why?
| | Islets of Langerhans Transplantation | 1 | 2017 | 64 | 0.130 |
Why?
| | Antibodies | 3 | 2015 | 410 | 0.130 |
Why?
| | Melanoma | 2 | 2022 | 760 | 0.120 |
Why?
| | Epitopes | 3 | 2007 | 479 | 0.120 |
Why?
| | Myeloid Differentiation Factor 88 | 3 | 2011 | 99 | 0.120 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 2 | 2016 | 336 | 0.120 |
Why?
| | Receptors, Tumor Necrosis Factor | 1 | 2016 | 164 | 0.120 |
Why?
| | Triple Negative Breast Neoplasms | 1 | 2018 | 202 | 0.120 |
Why?
| | Caspases, Initiator | 1 | 2015 | 17 | 0.120 |
Why?
| | AIDS Vaccines | 2 | 2005 | 52 | 0.120 |
Why?
| | Minor Histocompatibility Antigens | 1 | 2015 | 48 | 0.120 |
Why?
| | DNA-Binding Proteins | 2 | 2018 | 1502 | 0.120 |
Why?
| | Antibody Formation | 2 | 2013 | 298 | 0.120 |
Why?
| | Toll-Like Receptor 9 | 2 | 2006 | 32 | 0.110 |
Why?
| | Neoplasm Proteins | 1 | 2018 | 434 | 0.110 |
Why?
| | Host-Pathogen Interactions | 1 | 2018 | 364 | 0.110 |
Why?
| | Immunoglobulin G | 5 | 2022 | 893 | 0.110 |
Why?
| | Reoviridae | 1 | 1995 | 37 | 0.110 |
Why?
| | Skin Transplantation | 1 | 2015 | 85 | 0.110 |
Why?
| | Smallpox Vaccine | 1 | 2014 | 23 | 0.110 |
Why?
| | Adenocarcinoma | 1 | 2022 | 940 | 0.110 |
Why?
| | Coculture Techniques | 1 | 2015 | 239 | 0.110 |
Why?
| | Receptors, Cytokine | 1 | 2014 | 36 | 0.110 |
Why?
| | STAT Transcription Factors | 1 | 2014 | 17 | 0.110 |
Why?
| | Receptors, Interleukin | 1 | 2014 | 45 | 0.110 |
Why?
| | Antibodies, Neutralizing | 1 | 2017 | 286 | 0.110 |
Why?
| | Dose-Response Relationship, Immunologic | 1 | 2014 | 82 | 0.110 |
Why?
| | Pandemics | 1 | 2023 | 1639 | 0.110 |
Why?
| | Tumor Cells, Cultured | 3 | 2021 | 955 | 0.110 |
Why?
| | Sequence Homology, Amino Acid | 1 | 1995 | 385 | 0.110 |
Why?
| | Virus Replication | 1 | 2017 | 483 | 0.110 |
Why?
| | Capsid Proteins | 1 | 1995 | 94 | 0.110 |
Why?
| | Colorado | 2 | 2021 | 4565 | 0.110 |
Why?
| | Leukocytes, Mononuclear | 3 | 2013 | 558 | 0.110 |
Why?
| | Gangliosides | 1 | 2013 | 20 | 0.100 |
Why?
| | Growth Hormone | 1 | 2013 | 101 | 0.100 |
Why?
| | Proto-Oncogene Proteins pp60(c-src) | 1 | 2013 | 11 | 0.100 |
Why?
| | Autoantigens | 1 | 2016 | 430 | 0.100 |
Why?
| | Positive Regulatory Domain I-Binding Factor 1 | 1 | 2013 | 18 | 0.100 |
Why?
| | Genes, MHC Class II | 1 | 2013 | 74 | 0.100 |
Why?
| | Transplantation Chimera | 1 | 2013 | 54 | 0.100 |
Why?
| | Phenotype | 2 | 2019 | 3196 | 0.100 |
Why?
| | Clone Cells | 4 | 2001 | 265 | 0.100 |
Why?
| | Whole-Body Irradiation | 1 | 2013 | 78 | 0.100 |
Why?
| | Muramidase | 1 | 2012 | 78 | 0.100 |
Why?
| | Guidelines as Topic | 1 | 2014 | 275 | 0.100 |
Why?
| | Receptors, Antigen, T-Cell, gamma-delta | 1 | 2012 | 101 | 0.100 |
Why?
| | Histocompatibility Antigens Class II | 2 | 2007 | 367 | 0.100 |
Why?
| | T-Lymphocytes, Regulatory | 3 | 2025 | 385 | 0.090 |
Why?
| | Antigenic Variation | 1 | 2011 | 10 | 0.090 |
Why?
| | Recombinant Proteins | 2 | 2013 | 1353 | 0.090 |
Why?
| | Moloney murine leukemia virus | 1 | 2011 | 13 | 0.090 |
Why?
| | Receptors, Interleukin-12 | 1 | 2011 | 7 | 0.090 |
Why?
| | Thymus Gland | 1 | 2013 | 312 | 0.090 |
Why?
| | Toll-Like Receptor 3 | 2 | 2014 | 28 | 0.090 |
Why?
| | Myocarditis | 1 | 2012 | 100 | 0.090 |
Why?
| | Cell Line, Tumor | 4 | 2025 | 3412 | 0.090 |
Why?
| | Transplantation, Homologous | 3 | 2017 | 416 | 0.090 |
Why?
| | Immunoglobulin E | 1 | 2012 | 342 | 0.090 |
Why?
| | Viral Envelope Proteins | 1 | 2011 | 84 | 0.090 |
Why?
| | RNA-Binding Proteins | 1 | 1995 | 422 | 0.090 |
Why?
| | Nasal Mucosa | 1 | 2011 | 107 | 0.080 |
Why?
| | Hyaluronan Receptors | 2 | 2009 | 102 | 0.080 |
Why?
| | Nucleic Acids | 1 | 2011 | 71 | 0.080 |
Why?
| | Time Factors | 1 | 2021 | 6828 | 0.080 |
Why?
| | Body Weight | 1 | 2014 | 985 | 0.080 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2015 | 860 | 0.080 |
Why?
| | Macaca mulatta | 3 | 2019 | 166 | 0.080 |
Why?
| | Breast Neoplasms | 1 | 2022 | 2253 | 0.080 |
Why?
| | Toll-Like Receptor 5 | 1 | 2009 | 14 | 0.080 |
Why?
| | Polyethyleneimine | 1 | 2009 | 18 | 0.080 |
Why?
| | Granzymes | 2 | 2022 | 50 | 0.080 |
Why?
| | Organ Specificity | 2 | 2001 | 305 | 0.080 |
Why?
| | Toll-Like Receptor 8 | 2 | 2006 | 6 | 0.080 |
Why?
| | Lymphocytes, Tumor-Infiltrating | 2 | 2022 | 210 | 0.080 |
Why?
| | Liver | 2 | 2016 | 1943 | 0.080 |
Why?
| | Amino Acid Sequence | 3 | 2016 | 2139 | 0.080 |
Why?
| | Injections, Intravenous | 2 | 2013 | 206 | 0.080 |
Why?
| | Bronchial Hyperreactivity | 1 | 2009 | 111 | 0.070 |
Why?
| | Anti-Inflammatory Agents | 1 | 2012 | 496 | 0.070 |
Why?
| | Kupffer Cells | 1 | 2008 | 50 | 0.070 |
Why?
| | Lectins, C-Type | 2 | 2020 | 67 | 0.070 |
Why?
| | Proto-Oncogene Proteins | 2 | 2002 | 648 | 0.070 |
Why?
| | Autoimmune Diseases | 1 | 2012 | 460 | 0.070 |
Why?
| | Transcription, Genetic | 1 | 2014 | 1457 | 0.070 |
Why?
| | Baculoviridae | 1 | 2008 | 44 | 0.070 |
Why?
| | Protein Binding | 2 | 2022 | 2224 | 0.070 |
Why?
| | Insecta | 1 | 2008 | 67 | 0.070 |
Why?
| | Interleukin-6 | 1 | 2012 | 778 | 0.070 |
Why?
| | B7-1 Antigen | 3 | 2009 | 58 | 0.070 |
Why?
| | Interferon Inducers | 2 | 2008 | 8 | 0.070 |
Why?
| | Major Histocompatibility Complex | 2 | 2008 | 227 | 0.070 |
Why?
| | Saccharomyces cerevisiae | 1 | 2012 | 557 | 0.070 |
Why?
| | Tumor Microenvironment | 2 | 2022 | 674 | 0.070 |
Why?
| | Research Personnel | 1 | 2009 | 173 | 0.070 |
Why?
| | RNA, Small Interfering | 1 | 2009 | 622 | 0.070 |
Why?
| | Histocompatibility Antigen H-2D | 2 | 2008 | 21 | 0.060 |
Why?
| | Injections, Intradermal | 1 | 2006 | 13 | 0.060 |
Why?
| | Oleic Acids | 1 | 2006 | 11 | 0.060 |
Why?
| | Mannitol | 1 | 2006 | 38 | 0.060 |
Why?
| | Injections, Intraperitoneal | 2 | 2013 | 114 | 0.060 |
Why?
| | Inflammation Mediators | 1 | 2009 | 513 | 0.060 |
Why?
| | T-Lymphocytes, Cytotoxic | 2 | 2022 | 173 | 0.060 |
Why?
| | Immunosuppressive Agents | 2 | 2009 | 890 | 0.060 |
Why?
| | HIV Antigens | 1 | 2005 | 18 | 0.060 |
Why?
| | Oligodeoxyribonucleotides | 4 | 2006 | 143 | 0.060 |
Why?
| | Neoplasms, Experimental | 1 | 2006 | 176 | 0.060 |
Why?
| | STAT5 Transcription Factor | 1 | 2025 | 57 | 0.060 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2013 | 1040 | 0.060 |
Why?
| | Lung Neoplasms | 1 | 2018 | 2526 | 0.060 |
Why?
| | Forkhead Box Protein O1 | 1 | 2025 | 33 | 0.060 |
Why?
| | Core Binding Factor Alpha 1 Subunit | 1 | 2025 | 40 | 0.060 |
Why?
| | Cell Adhesion | 1 | 2006 | 466 | 0.060 |
Why?
| | CD40 Ligand | 2 | 2018 | 41 | 0.060 |
Why?
| | Genes, Reporter | 2 | 2002 | 269 | 0.060 |
Why?
| | Cytotoxicity Tests, Immunologic | 1 | 2004 | 41 | 0.050 |
Why?
| | Transfection | 3 | 2019 | 945 | 0.050 |
Why?
| | Acute Kidney Injury | 1 | 2012 | 815 | 0.050 |
Why?
| | Ovarian Neoplasms | 1 | 2009 | 565 | 0.050 |
Why?
| | Neoplasms | 2 | 2009 | 2671 | 0.050 |
Why?
| | Interleukin-2 Receptor alpha Subunit | 1 | 2023 | 81 | 0.050 |
Why?
| | Genes, bcl-2 | 1 | 2002 | 21 | 0.050 |
Why?
| | Leukemia | 1 | 2025 | 240 | 0.050 |
Why?
| | Apoptosis | 1 | 2011 | 2553 | 0.050 |
Why?
| | Ubiquitin C | 1 | 2001 | 3 | 0.050 |
Why?
| | Interphase | 2 | 1999 | 32 | 0.050 |
Why?
| | Asthma | 2 | 2012 | 2295 | 0.050 |
Why?
| | THP-1 Cells | 1 | 2021 | 22 | 0.050 |
Why?
| | Pregnancy | 1 | 2014 | 6763 | 0.050 |
Why?
| | CTLA-4 Antigen | 2 | 2019 | 99 | 0.050 |
Why?
| | Cytoskeletal Proteins | 1 | 2022 | 158 | 0.050 |
Why?
| | Polymerization | 1 | 2022 | 124 | 0.050 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2002 | 233 | 0.050 |
Why?
| | Lymph Node Excision | 1 | 2022 | 171 | 0.050 |
Why?
| | Chemotaxis, Leukocyte | 1 | 2001 | 136 | 0.050 |
Why?
| | World Health Organization | 1 | 2022 | 123 | 0.040 |
Why?
| | Transcriptome | 2 | 2019 | 971 | 0.040 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2001 | 767 | 0.040 |
Why?
| | Macromolecular Substances | 1 | 2001 | 229 | 0.040 |
Why?
| | Cell Line | 2 | 2005 | 2847 | 0.040 |
Why?
| | Programmed Cell Death 1 Receptor | 1 | 2023 | 249 | 0.040 |
Why?
| | Middle Aged | 3 | 2021 | 33479 | 0.040 |
Why?
| | Intraepithelial Lymphocytes | 1 | 2020 | 15 | 0.040 |
Why?
| | Tumor Burden | 1 | 2022 | 309 | 0.040 |
Why?
| | Receptors, Mitogen | 1 | 2020 | 9 | 0.040 |
Why?
| | Acrylic Resins | 1 | 2020 | 46 | 0.040 |
Why?
| | Drug Screening Assays, Antitumor | 1 | 2021 | 194 | 0.040 |
Why?
| | Drosophila Proteins | 1 | 2002 | 204 | 0.040 |
Why?
| | STAT3 Transcription Factor | 1 | 2022 | 206 | 0.040 |
Why?
| | Green Fluorescent Proteins | 1 | 2001 | 390 | 0.040 |
Why?
| | Keratinocytes | 1 | 2021 | 249 | 0.040 |
Why?
| | RNA, Viral | 1 | 2024 | 656 | 0.040 |
Why?
| | Mice, Inbred Strains | 1 | 2000 | 409 | 0.040 |
Why?
| | Combined Modality Therapy | 1 | 2022 | 1236 | 0.040 |
Why?
| | Disease Susceptibility | 1 | 2021 | 347 | 0.040 |
Why?
| | Lipopolysaccharides | 4 | 2006 | 886 | 0.040 |
Why?
| | Gene Expression Profiling | 3 | 2002 | 1774 | 0.040 |
Why?
| | Arthritis | 1 | 2020 | 95 | 0.040 |
Why?
| | Cell Compartmentation | 1 | 2019 | 52 | 0.040 |
Why?
| | Clonal Anergy | 1 | 1999 | 52 | 0.040 |
Why?
| | HIV-1 | 1 | 2005 | 864 | 0.040 |
Why?
| | Aged | 2 | 2016 | 23961 | 0.040 |
Why?
| | Recombinant Fusion Proteins | 1 | 2001 | 665 | 0.040 |
Why?
| | Intercellular Adhesion Molecule-1 | 1 | 1999 | 139 | 0.040 |
Why?
| | Homozygote | 1 | 2019 | 203 | 0.040 |
Why?
| | Survival Analysis | 1 | 2022 | 1325 | 0.040 |
Why?
| | Siblings | 1 | 2019 | 228 | 0.040 |
Why?
| | Plasmids | 2 | 2011 | 363 | 0.040 |
Why?
| | Immunoconjugates | 1 | 1999 | 114 | 0.030 |
Why?
| | Cations | 2 | 2009 | 84 | 0.030 |
Why?
| | Genome | 1 | 2000 | 300 | 0.030 |
Why?
| | Receptors, Immunologic | 1 | 2019 | 216 | 0.030 |
Why?
| | Acute Disease | 1 | 2020 | 1007 | 0.030 |
Why?
| | Adult | 2 | 2021 | 37929 | 0.030 |
Why?
| | Cytomegalovirus Infections | 1 | 2019 | 192 | 0.030 |
Why?
| | Promoter Regions, Genetic | 1 | 2001 | 1250 | 0.030 |
Why?
| | Arenaviridae Infections | 1 | 2016 | 8 | 0.030 |
Why?
| | Cell Degranulation | 1 | 2016 | 41 | 0.030 |
Why?
| | Cell Separation | 2 | 2012 | 318 | 0.030 |
Why?
| | Skin | 1 | 2021 | 752 | 0.030 |
Why?
| | Biomarkers | 2 | 2021 | 4149 | 0.030 |
Why?
| | Lymphocytic choriomeningitis virus | 1 | 2016 | 29 | 0.030 |
Why?
| | Carboxymethylcellulose Sodium | 1 | 2015 | 3 | 0.030 |
Why?
| | Polylysine | 1 | 2015 | 17 | 0.030 |
Why?
| | CpG Islands | 2 | 2006 | 157 | 0.030 |
Why?
| | Histocompatibility Testing | 1 | 2015 | 126 | 0.030 |
Why?
| | Molecular Sequence Data | 2 | 2001 | 2900 | 0.030 |
Why?
| | Cellular Senescence | 1 | 2016 | 189 | 0.030 |
Why?
| | Chronic Disease | 1 | 2020 | 1793 | 0.030 |
Why?
| | Disease Progression | 1 | 2022 | 2757 | 0.030 |
Why?
| | Down-Regulation | 2 | 2011 | 657 | 0.030 |
Why?
| | Hypodermoclysis | 1 | 2013 | 4 | 0.030 |
Why?
| | Antiviral Agents | 1 | 2020 | 744 | 0.030 |
Why?
| | Models, Molecular | 1 | 2019 | 1570 | 0.030 |
Why?
| | Stem Cells | 1 | 1998 | 594 | 0.030 |
Why?
| | Chemistry, Pharmaceutical | 1 | 2013 | 105 | 0.030 |
Why?
| | Species Specificity | 1 | 1995 | 585 | 0.030 |
Why?
| | Polymerase Chain Reaction | 1 | 2016 | 1062 | 0.030 |
Why?
| | Immunological Synapses | 1 | 2012 | 16 | 0.020 |
Why?
| | Interleukin-1 | 2 | 2012 | 965 | 0.020 |
Why?
| | Rats, Inbred Lew | 1 | 2012 | 114 | 0.020 |
Why?
| | Respiratory Mucosa | 1 | 2015 | 321 | 0.020 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2015 | 652 | 0.020 |
Why?
| | Interferon-alpha | 2 | 2005 | 198 | 0.020 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2013 | 346 | 0.020 |
Why?
| | Inflammation | 2 | 2020 | 2837 | 0.020 |
Why?
| | Particle Size | 1 | 2013 | 394 | 0.020 |
Why?
| | Cattle | 1 | 1995 | 984 | 0.020 |
Why?
| | Clodronic Acid | 1 | 2012 | 17 | 0.020 |
Why?
| | Chemokine CXCL1 | 1 | 2012 | 76 | 0.020 |
Why?
| | Aerosols | 1 | 2012 | 176 | 0.020 |
Why?
| | Diphtheria Toxin | 1 | 2012 | 66 | 0.020 |
Why?
| | Chemokine CCL2 | 1 | 2012 | 115 | 0.020 |
Why?
| | Melioidosis | 1 | 2011 | 5 | 0.020 |
Why?
| | Burkholderia pseudomallei | 1 | 2011 | 10 | 0.020 |
Why?
| | Bone Marrow | 1 | 2013 | 286 | 0.020 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2012 | 152 | 0.020 |
Why?
| | Administration, Intranasal | 1 | 2011 | 90 | 0.020 |
Why?
| | Models, Animal | 1 | 2013 | 384 | 0.020 |
Why?
| | Administration, Inhalation | 1 | 2012 | 688 | 0.020 |
Why?
| | Th17 Cells | 1 | 2012 | 108 | 0.020 |
Why?
| | Phylogeny | 1 | 1995 | 904 | 0.020 |
Why?
| | Lipoproteins | 1 | 2012 | 168 | 0.020 |
Why?
| | Cysteine | 1 | 2012 | 204 | 0.020 |
Why?
| | Pulmonary Emphysema | 1 | 2013 | 288 | 0.020 |
Why?
| | Weight Gain | 1 | 2013 | 519 | 0.020 |
Why?
| | Interleukin-1beta | 1 | 2012 | 372 | 0.020 |
Why?
| | Methacholine Chloride | 1 | 2009 | 52 | 0.020 |
Why?
| | Echocardiography | 1 | 2012 | 642 | 0.020 |
Why?
| | Prostaglandin D2 | 1 | 2008 | 23 | 0.020 |
Why?
| | Ischemia | 1 | 2012 | 409 | 0.020 |
Why?
| | Cell Death | 2 | 2001 | 374 | 0.020 |
Why?
| | Heart | 1 | 2012 | 655 | 0.020 |
Why?
| | CD4 Antigens | 1 | 2009 | 141 | 0.020 |
Why?
| | Cell Transplantation | 1 | 2008 | 37 | 0.020 |
Why?
| | Dinoprostone | 1 | 2008 | 191 | 0.020 |
Why?
| | Metabolomics | 1 | 2013 | 678 | 0.020 |
Why?
| | Cell Survival | 2 | 2002 | 1120 | 0.020 |
Why?
| | Mice, Mutant Strains | 1 | 2007 | 298 | 0.020 |
Why?
| | Risk Factors | 1 | 2021 | 10388 | 0.020 |
Why?
| | Zymosan | 1 | 2006 | 65 | 0.020 |
Why?
| | Nucleocapsid Proteins | 1 | 2005 | 23 | 0.020 |
Why?
| | Age Factors | 1 | 2013 | 3295 | 0.010 |
Why?
| | Neoplasm Metastasis | 1 | 2008 | 658 | 0.010 |
Why?
| | Primates | 1 | 2005 | 126 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2019 | 10811 | 0.010 |
Why?
| | Rats | 1 | 2012 | 5647 | 0.010 |
Why?
| | Ligands | 1 | 2005 | 664 | 0.010 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2006 | 430 | 0.010 |
Why?
| | Nitric Oxide | 1 | 2008 | 915 | 0.010 |
Why?
| | bcl-X Protein | 1 | 2002 | 43 | 0.010 |
Why?
| | Mycobacterium tuberculosis | 1 | 2006 | 314 | 0.010 |
Why?
| | Superantigens | 1 | 2002 | 70 | 0.010 |
Why?
| | Interleukin-3 | 1 | 2002 | 25 | 0.010 |
Why?
| | Receptors, CCR7 | 1 | 2002 | 32 | 0.010 |
Why?
| | Receptors, Chemokine | 1 | 2002 | 47 | 0.010 |
Why?
| | Models, Immunological | 1 | 2002 | 100 | 0.010 |
Why?
| | Chemokines, CXC | 1 | 2002 | 70 | 0.010 |
Why?
| | Genetic Variation | 1 | 2007 | 991 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2013 | 7635 | 0.010 |
Why?
| | Aging | 1 | 2011 | 1864 | 0.010 |
Why?
| | Cell Division | 1 | 2002 | 794 | 0.010 |
Why?
| | Phorbol Esters | 1 | 2000 | 14 | 0.010 |
Why?
| | Expressed Sequence Tags | 1 | 2000 | 42 | 0.010 |
Why?
| | Jurkat Cells | 1 | 2000 | 134 | 0.010 |
Why?
| | Abatacept | 1 | 1999 | 53 | 0.010 |
Why?
| | Nucleic Acid Hybridization | 1 | 1999 | 190 | 0.010 |
Why?
| | Antigens, Differentiation | 1 | 1999 | 83 | 0.010 |
Why?
| | Hybridomas | 1 | 1999 | 237 | 0.010 |
Why?
| | Immunization, Secondary | 1 | 1999 | 87 | 0.010 |
Why?
| | Antioxidants | 1 | 2002 | 584 | 0.010 |
Why?
| | NF-kappa B | 1 | 2002 | 691 | 0.010 |
Why?
| | Hot Temperature | 1 | 2000 | 391 | 0.010 |
Why?
| | Databases, Factual | 1 | 2000 | 1357 | 0.010 |
Why?
|
|
Kedl's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|